Literature DB >> 8183931

High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.

J Hammer1, C Belunis, D Bolin, J Papadopoulos, R Walsky, J Higelin, W Danho, F Sinigaglia, Z A Nagy.   

Abstract

We have previously identified four anchor positions in HLA-DRB1*0101-binding peptides, and three anchors involved in peptide binding to DRB1*0401 and DRB1*1101 molecules, by screening of an M13 peptide display library (approximately 20 million independent nonapeptides) for DR-binding activity. In this study, high stringency screening of the M13 library for DRB1*0401 binding has resulted in identification of three further anchor positions. Taken together, a peptide-binding motif has been obtained, in which six of seven positions show enrichment of certain residues. We have demonstrated an additive effect of anchors in two different ways: (i) the addition of more anchors is shown to compensate for progressive truncation of designer peptides; (ii) the incorporation of an increasing number of anchors into 6- or 7-residue-long designer peptides is shown to result in a gradual increase of binding affinity to the level of 13-residue-long high-affinity epitopes. The anchor at relative position 1 seems to be obligatory, in that its substitution abrogates binding completely, whereas the elimination of other anchors results only in partial loss of binding affinity. The spacing between anchors is critical, since their effect is lost by shifting them one position toward the N or C terminus. The information born out of this study has been successfully used to identify DR-binding sequences from natural proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8183931      PMCID: PMC43804          DOI: 10.1073/pnas.91.10.4456

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.

Authors:  D H Fremont; M Matsumura; E A Stura; P A Peterson; I A Wilson
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  Peptide binding to soluble HLA-DR4 molecules produced by insect cells.

Authors:  A Scheirle; B Takacs; L Kremer; F Marin; F Sinigaglia
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

3.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.

Authors:  D F Hunt; H Michel; T A Dickinson; J Shabanowitz; A L Cox; K Sakaguchi; E Appella; H M Grey; A Sette
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

4.  The primary structure of human cartilage link protein.

Authors:  J Dudhia; T E Hardingham
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

5.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

6.  Promiscuous and allele-specific anchors in HLA-DR-binding peptides.

Authors:  J Hammer; P Valsasnini; K Tolba; D Bolin; J Higelin; B Takacs; F Sinigaglia
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

7.  Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.

Authors:  W Zhang; A C Young; M Imarai; S G Nathenson; J C Sacchettini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

8.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

9.  Identification of a motif for HLA-DR1 binding peptides using M13 display libraries.

Authors:  J Hammer; B Takacs; F Sinigaglia
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

10.  Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.

Authors:  U Eisel; W Jarausch; K Goretzki; A Henschen; J Engels; U Weller; M Hudel; E Habermann; H Niemann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  38 in total

1.  Hindering auxiliary anchors are potent modulators of peptide binding and selection by I-Ak class II molecules.

Authors:  R R Latek; S J Petzold; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  High-throughput engineering and analysis of peptide binding to class II MHC.

Authors:  Wei Jiang; Eric T Boder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-09       Impact factor: 11.205

3.  Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.

Authors:  Kazuyuki Kawamura; Katherine A McLaughlin; Robert Weissert; Thomas G Forsthuber
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

4.  An empirical method for the prediction of T-cell epitopes.

Authors:  M P Davenport; I A Ho Shon; A V Hill
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/II.

Authors:  C G Kelly; S Todryk; H L Kendal; G H Munro; T Lehner
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.

Authors:  B S Nepom; G T Nepom; M Coleman; W W Kwok
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 7.  Selection of the MHC class II-associated peptide repertoire by HLA-DM.

Authors:  S O Arndt; A B Vogt; G J Hämmerling; H Kropshofer
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

8.  Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

Authors:  P Stumptner; P Benaroch
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

Review 9.  The optimization of helper T lymphocyte (HTL) function in vaccine development.

Authors:  J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

10.  Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.

Authors:  M C Honeyman; L C Harrison; B Drummond; P G Colman; B D Tait
Journal:  Mol Med       Date:  1995-07       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.